Anna Bochowicz

Anna Bochowicz

Auto-generated profile, based on publicly available information

Anna Bochowicz

Department of Cardiology, Institute of Mother and Child, Warszawa, Poland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Chest
Verified
Journal Article
Closed access
PPPiotr Pruszczyk
Piotr Pruszczyk
ABAnna Bochowicz
Anna Bochowicz
Adam TorbickiAdam Torbicki
Adam Torbicki
MSMarcin Szulc
Marcin Szulc
Marcin Kurzyna, MD, PhD, FESCMarcin Kurzyna, MD, PhD, FESC
Marcin Kurzyna, MD, PhD, FESC
AKAgnieszka Kuch-Wocial
Agnieszka Kuch-Wocial

23 May 2005 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MKMaciej Kostrubiec
Maciej Kostrubiec
PPPiotr Pruszczyk
Piotr Pruszczyk
ABAnna Bochowicz
Anna Bochowicz
RPRyszard Pacho
Ryszard Pacho
MSMarcin Szulc
Marcin Szulc
KKKrystyna Kuczynska
Krystyna Kuczynska
Aims Despite growing interest in biomarkers application for risk evaluation in acute pulmonary embolism (APE), no decision-making levels have been defined. Methods and results We developed a biomarker-based risk stratification in 100 consecutive, normotensive on admission, APE patients (35 males, 65 females, 62±18 years). On admission serum NT-proBNP and cardiac troponin T (cTnT) levels were assessed and echocardiography was performed. All-cause 40-day mortality was 15% and APE mortality was 8%. In univariable analysis, cTnT>0.07 µg/L predicted all-cause mortality, hazard ratio (HR) 9.2 (95% CI: 3.3–26.1, P7600 ng/L predicted all-cause and APE mortalities [HR 6.7 (95% CI: 2.4–19.0, P=0.0003) and 7.3 (95% CI: 1.7–30.6, P=0.007)]. NT-proBNP0.07 µg/L was the most significant independent predictor, whereas NT-proBNP and systemic systolic blood pressure measured on admission and echocardiographic parameters were non-significant. APE mortality in patients with NT-proBNP≥600 ng/L and cTnT≥0.07 µg/L reached 33%. NT-proBNP<600 ng/L indicated group without deaths. APE mortality for patients with NT-proBNP≥600 ng/L and cTnT<0.07 µg/L was 3.7%. Incorporation of echocardiographic data did not improve group selection. Conclusion Simultaneous measurement of serum cTnT and NT-proBNP allows for precise APE prognosis. Normotensive patients on admission with cTnT≥0.07 µg/L and NT-proBNP≥600 ng/L are at high risk of APE mortality, whereas NTproBNP<600 ng/L indicates excellent prognosis.

1 October 2003 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
PPP. Pruszczyk
P. Pruszczyk
MKM. Kostrubiec
M. Kostrubiec
ABA. Bochowicz
A. Bochowicz
GSGrzegorz Styczynski
Grzegorz Styczynski
MSM. Szulc
M. Szulc
Adam TorbickiAdam Torbicki
Adam Torbicki
Plasma brain natriuretic peptide (BNP), released from myocytes of ventricles upon stretch, has been reported to differentiate pulmonary from cardiac dyspnoea. Limited data have shown elevated plasma BNP levels in acute pulmonary embolism (APE), frequently accompanied by dyspnoea and right ventricular (RV) dysfunction. The aim of this study was to assess plasma N‐terminal proBNP (NT‐proBNP) in APE, and to establish whether it reflects the severity of RV overload and if it can be used to predict adverse clinical outcome.On admission, NT‐proBNP and echocardiography for RV overload were performed in 79 APE patients (29 males), aged 63±16 yrs.Plasma NT‐proBNP was elevated in 66 patients (83.5%) and was higher in patients with (median 4,650 pg·mL−1(range 61–60,958)) than without RV strain (363 pg·mL−1(16–16,329)). RV‐to-left ventricular ratio and inferior vena cava dimension correlated with NT‐proBNP. All 15 in-hospital deaths and 24 serious adverse events occurred in the group with elevated NT‐proBNP, while all 13 (16.5%) patients with normal values had an uncomplicated clinical course. Plasma NT‐proBNP predicted in-hospital mortality.Plasma N‐terminal pro-brain natriuretic peptide is elevated in the majority of cases of pulmonary embolism resulting in right ventricular overload. Plasma levels reflect the degree of right ventricular overload and may help to predict short-term outcome. Acute pulmonary embolism should be considered in the differential diagnosis of patients with dyspnoea and abnormal levels of brain natriuretic peptide.

1 September 2006 in Clinica Chimica Acta
Verified
Journal Article
Closed access
AKAnna Kaczyñska
Anna Kaczyñska
MPMaurice M.A.L. Pelsers
Maurice M.A.L. Pelsers
ABAnna Bochowicz
Anna Bochowicz
MKMaciej Kostrubiec
Maciej Kostrubiec
JGJan F.C. Glatz
Jan F.C. Glatz
PPPiotr Pruszczyk
Piotr Pruszczyk

1 March 2003 in Heart
Verified
Journal Article
Open access
PDF file
PPP Pruszczyk
P Pruszczyk
RPR Pacho
R Pacho
MCMichał Ciurzyński
Michał Ciurzyński
Marcin Kurzyna, MD, PhD, FESCMarcin Kurzyna, MD, PhD, FESC
Marcin Kurzyna, MD, PhD, FESC
BBB Burakowska
B Burakowska
Adam TorbickiAdam Torbicki
Adam Torbicki
Saddle PE was documented with spiral CT in 17 patients (10 men, 7 women, mean (SD) age 66 (11) years) out of 289 consecutive patients with tomographically diagnosed PE (5.2%). The saddle PE (S-PE) group was compared to 44 consecutive patients (17 men, 27 women, aged 66 (13) years with central, defined as at least lobar, non-saddle PE (NS-PE) proven by spiral CT. At the time of the diagnosis all patients underwent transthoracic echocardiography for the assessment of right ventricular pressure overload.

27 October 2003 in Clinica Chimica Acta
Verified
Journal Article
Closed access
PPPiotr Pruszczyk
Piotr Pruszczyk
ABAnna Bochowicz
Anna Bochowicz
MKMaciej Kostrubiec
Maciej Kostrubiec
Adam TorbickiAdam Torbicki
Adam Torbicki
MSMarcin Szulc
Marcin Szulc
HBHanna Berent
Hanna Berent